BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3935176)

  • 1. [A new fluorogenic substrate for human galactocerebroside-beta-D-galactosidase].
    Vidershaĭn GIa; Kozlova IK; Il'ina GS
    Biokhimiia; 1985 Oct; 50(10):1665-7. PubMed ID: 3935176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the specificity of human lysosomal glycolipid hydrolases using synthetic fluorogenic substrates].
    Vidershaĭn GIa; Kozlova IK; Il'ina GS; Mikhaĭlova MA
    Bioorg Khim; 1988 Aug; 14(8):1014-26. PubMed ID: 3146253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of Krabbe disease in 2 brothers from East Germany using a new fluorogenic substrate for galactocerebrosidase].
    Vidershaĭn GIa; Zschiesche M; Seidlitz G
    Vopr Med Khim; 1988; 34(1):87-9. PubMed ID: 3369131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of various properties of beta-galactocerebrosidase from human chorion using synthetic fluorescent substrates].
    Petushkova NA; Kozlova IK; Tsvetkova IV; Vidershaĭn GIa
    Biokhimiia; 1988 Sep; 53(9):1539-45. PubMed ID: 3203114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of spectrophotometric and fluorimetric methods of determination of galactocerebroside-beta-D-galactosidase in leukocytes].
    Gusina NB; Tsukerman GL
    Vopr Med Khim; 1988; 34(4):129-31. PubMed ID: 3195126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a fluorescent analogue of galactocerebroside for assay of galactocerebroside beta-galactosidase activity in skin fibroblasts from patients with Krabbe's disease.
    Okada S; Kato T; Yabuuchi H; Yoshino K; Naoi M; Kiuchi K; Yagi K
    Clin Chim Acta; 1984 Jan; 136(1):57-63. PubMed ID: 6692566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactosylceramidase assays for diagnosis of globoid cell leukodystrophy and GM1-gangliosidosis.
    Tanaka H; Suzuki K
    Clin Chim Acta; 1977 Mar; 75(2):267-74. PubMed ID: 403037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D- galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease.
    Wiederschain G; Raghavan S; Kolodny E
    Clin Chim Acta; 1992 Jan; 205(1-2):87-96. PubMed ID: 1521344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A practical chromogenic procedure for the diagnosis of Krabbe's disease.
    Gal AE; Brady RO; Pentchev PG; Furbish FS; Suzuki K; Tanaka H; Schneider EL
    Clin Chim Acta; 1977 May; 77(1):53-9. PubMed ID: 17489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of natural and artifical substrates in the prenatal diagnosis of Krabbe's disease.
    Besley GT
    J Inherit Metab Dis; 1978; 1(3):115-8. PubMed ID: 116080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical diagnosis of globoid cell leukodystrophy (Krabbe's disease)].
    Tsvetkova IV; Zolotukhina TV; Rozenfel'd RA
    Vopr Med Khim; 1985; 31(2):128-30. PubMed ID: 2860752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester diagnosis of Krabbe's disease by direct enzyme analysis of chorionic villi.
    Kleijer WJ; Mancini GM; Jahoda MG; Vosters RP; Sachs ES; Niermeijer MF; Galjaard H
    N Engl J Med; 1984 Nov; 311(19):1257. PubMed ID: 6493280
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases.
    Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y
    J Biol Chem; 1985 Dec; 260(28):14982-7. PubMed ID: 3934152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity of galactosylceramidase activation by phosphatidylserine.
    Hanada E; Suzuki K
    Biochim Biophys Acta; 1980 Aug; 619(2):396-402. PubMed ID: 6773584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylceramide- and lactosylceramide-loading studies in cultured fibroblasts from normal individuals and patients with globoid cell leukodystrophy (Krabbe's disease) and GM1-gangliosidosis.
    Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y; Okawauchi M; Sugihara G; Tanaka M
    Biochim Biophys Acta; 1985 Jul; 835(3):456-64. PubMed ID: 3926002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a chromogenic substrate for the diagnosis of Krabbe's disease, with special reference to its application in prenatal diagnosis.
    Besley GT; Bain AD
    Clin Chim Acta; 1978 Sep; 88(2):229-36. PubMed ID: 699319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of loading tests with labeled GM1-ganglioside for differential diagnosis of GM1-gangliosidosis].
    Akhunov VS; Krasnopol'skaia KD; Mirenburg TV
    Vopr Med Khim; 1989; 35(5):119-22. PubMed ID: 2515652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a galactosylceramidase microassay method to early prenatal diagnosis of Krabbe's disease.
    Tsutsumi O; Satoh K; Sakamoto S; Suzuki Y; Kato T
    Clin Chim Acta; 1982 Nov; 125(3):265-73. PubMed ID: 7172437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.
    Besley GT; Bain AD
    J Med Genet; 1976 Jun; 13(3):195-9. PubMed ID: 819652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.